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ABSTRACT
Objective: The main aim of this study is to prevent biofilm formation by impregnating an antimicrobial on urinary catheter.
Methods: Catheter segments were immersed in the antimicrobial compound for impregnation. After 2 h, the segments were removed, sterilized and 
dried after which mechanical and antimicrobial properties of the catheter segments were determined. The shelf life of the impregnated segments was 
also ascertained as well as anti-biofilm assay. Spectral analysis (UV & FTIR) was also performed.
Results: Impregnation was achieved by immersing catheter segments in antimicrobial compound ensuring it does not affect the catheter texture. The 
impregnated antimicrobial catheters were able to prevent colonization by common uropathogens Escherichia coli, Proteus, Pseudomonas aeruginosa, 
Staphylococcus aureus, Klebsiella, and Candida albicans for up to 12 weeks. Antibiotic impregnation of the catheters did not affect the mechanical 
properties and did not render it as unfit for insertion. The antimicrobial-impregnated catheter offers a means of reducing biofilm formation and 
subsequently reducing the infection in long-term urinary catheter users. Spectral analysis was done by UV-Vis and FTIR.
Conclusion: Antibiotic impregnation of the catheters did not affect the mechanical properties and did not render it as unfit for insertion. The 
antimicrobial impregnated catheter offers a means of reducing biofilm formation and subsequently reducing the infection in long-term urinary 
catheter users.
Keywords: Biofilm, Catheter-associated urinary tract infections, Impregnation, Uropathogens.
INTRODUCTION
Urethral catheters are used to drain urine from the urinary bladder, 
especially in the management of intractable urinary problems such 
as chronic urinary retention, in the treatment of hospitalized and 
bedridden patients, including those affected by stroke, aged and those 
with injured spinal cords [1]. Consequently, device-related infections 
are a major cause of clinical complications. Increased health-care costs 
due to prolonged hospital stay or revision surgery and treatment of new 
ailments are other effects. To some extent, this could affect productivity 
of an individual. Reports suggest that up to 80% of nosocomial infections 
attributed to catheter-associated urinary tract infections (CAUTIs).
Longer periods of catheter insertion are a major cause of CAUTIs 
pathogenesis in which the sources of causative pathogens are from the 
hands of health-care personnel and also from the patients’ own flora, 
especially in the perineal area [2]. The migration of pathogens from 
the urine collection bags through both the inner and outer luminal 
surfaces of the catheter enters the urinary bladder and causes infection. 
During the migration of microorganisms along the luminal surface of 
the catheter, a number of interactions take place which determines 
the development of infection. The first step in biofilm formation 
is the adherence/attachment of free-floating microbes on the catheter 
surface, after which they form colonies and synthesize exopolymeric 
slime and form biofilm [3].
Naturally, bacteria grow in polymicrobial communities either as single 
species or coexist with other species to form a biofilm. Biofilm is an 
important virulence factor for pathogenic microbes [4]. These bacterial 
biofilms can develop on both biotic and abiotic surfaces [5]. The most 
common CAUTI pathogen is Escherichia coli, followed by Proteus 
mirabilis. Klebsiella pneumonia, Enterococci, and Staphylococci are 
less common, while Pseudomonas aeruginosa and Candida spp. may 
be observed in longer catheterized patients, especially after repeated 
courses of antibiotics [6]. This problem can be solved or controlled by 
the development of the modified catheter. The present study aims to 
modify a catheter using an antimicrobial compound from Streptomyces 
ABK07 to inhibit biofilm formation by the pathogens causing UTI.
MATERIALS AND METHODS
Impregnation of antimicrobial on catheter
The antimicrobial obtained from Streptomyces ABK07 [7] noted in previous 
published article was chosen for its activity against the CAUTI pathogens.
The antimicrobial was dissolved in methanol to give concentrations 
w/v of 0.2%. Latex Foley balloon catheter was cut into 2 mm segments 
and immersed in the solution for 2 h, during which the silicone swelled 
to almost double its volume. Then, the catheter pieces were removed 
and rinsed in absolute ethanol to remove residual antimicrobial 
compound after which they were left to dry at room temperature. After 
evaporation of the solvent, the catheters returned to their previous size, 
thus leaving the antimicrobial evenly distributed in the catheter pieces.
The catheter segments were then sterilized at 70°C for 15 min. The 
sterilization process did not affect the antimicrobial activity of the 
agent [8].
Mechanical properties of the catheter and balloon
Mechanical performance of catheter shafts was assessed using an 
Instron 5985 as described by Fisher et al. [9]. Both the control and 
antimicrobial-impregnated catheters were immersed in artificial 
urine; with the following composition (g/l): CaCl2.2H2 O - 0.651; 
MgCl2.6H2O - 0.651; NaCl - 4.6; Na2SO4 - 2.3; KH2PO4 - 2.8; KCl - 1.6; 
NH4Cl - 1.0; Urea - 25.0; creatine – 1.1; Tryptic Soy Broth (TSB) - 10.0; 
pH - 5.8; and sterilized by sieving through 0.2 µm pore size filter for 
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30 days at 37°C. While the balloon is inflated, the catheter tips were 
inserted through an inverted funnel, a 1 kg weight was applied to stretch 
the balloon against the neck of the funnel. Volume retention by the 
balloons was tested by inflating them with 10.0 ml of 0.5 g/l methylene 
blue and placing on a white absorbent background for 30 days [10]. 
The tests were performed in three replicates of each analysis at room 
temperature.
Antimicrobial activity of the antibiotic coated segments
Bridge plate method [11]
Mueller-Hinton agar plates seeded with test pathogens. Two wells, 
3 mm apart, were bored using the rear side of micropipette tips on the 
agar. The autoclaved antimicrobial-impregnated segments were placed 
on the bridge between the wells and gently pressed. The plates were 
then incubated at room temperature, and the zones of inhibition were 
measured after 24 h. The diameter of the zones of inhibition to the long 
axis of the catheter was measured. Unimpregnated catheter segments 
were used as controls.
Determination of shelf life
To check the activeness of the segments, the coated segments were 
stored at room temperature for 85 days and tested again for their 
antimicrobial activity.
Anti-biofilm assay
Biofilms were formed in synthetic urine composed as previously 
described. MHA medium supplemented with L-glutamine and buffered 
with morpholinepropanesulfonic acid containing 2 % glucose (w/v) 
with a final pH of 7.2 was used as a control for comparisons.
Two different in vitro models were used to assess biofilm growth and 
susceptibility to drugs. First, a microtiter plate-based model that utilizes 
polystyrene, flat bottom, and 96-microtiter plates as a substrate as 
previously described by Pierce et al. [12]. Cells were grown in nutrient 
broth medium overnight at 30°C, washed twice with sterile phosphate-
buffered saline (phosphate buffer -10 nM; potassium chloride - 2.7 mM; 
sodium chloride - 137 mM; and pH 7.4) resuspended in MHA adjusted 
to McFarland 0.5. 100 µl of inoculum was added to each well of a 96-
well microtiter plate. After 96 h of incubation at 37°C to allow for 
biofilm formation, the wells were washed 2 times with PBS to remove 
any non-adherent cells.
Second, biofilms were grown on silicon elastomer surfaces as described 
by Uppuluri et al. [13]. Briefly, the pathogenic strains were grown 
in MHA medium at 30°C overnight, washed in PBS, and diluted to a 
concentration of 5 × 106 cells/ml in MHA medium. The suspension was 
added to a sterile 24-well plate containing silicon elastomer squares. 
The inoculated plates were incubated at 37°C for 90 min for initial 
adhesion of cells. The squares were washed with PBS, transferred to 
fresh plates MHA medium, and incubated at 37°C for 96 h at 100 rpm 
to allow for biofilm formation. The degree of biofilm formation was 
estimated using XTT reduction assay [14]. For each assay, an aliquot of 
stock XTT was thawed, and 10 mM was added to a final concentration 
of 1 µM. 80 µl XTT-menadione solution was added to each prewashed 
biofilm and control wells. The microtiter plates were incubated in the 
dark at 37 °C for 2 h. Following incubation, 75 µl of XTT-menadione 
solution was transferred to the wells of a new microtiter plate, and the 
colorimetric change from XTT reduction was read in a microtiter plate 
reader at 490 nm.
Ultraviolet (UV) and Fourier transform-infrared (FTIR) spectral 
analysis
UV spectra of the antimicrobial compound were subjected to 
comparison of a general pattern, absorbance peaks and wavelength 
range. Each compound was determined in the UV region 200–400 nm 
using a Perkin Elmer Lambda 30 UV/Visual spectrophotometer.
After homogenization of the sample with KBR (1 mg of sample 
and 300 mg of KBr (IR grade) were mixed and a thin KBr disk was 
prepared). FTIR spectra of sample were analyzed. The FTIR spectrum of 
each compound was detected using SHIMADZU AUX 220 spectrometer 
in the range of 400–4000 cm−1 and plotted as intensity against wave 
number [15,16].
RESULTS
An efficient method must be used for the incorporation of the 
antimicrobial to ensure that both the external and internal surfaces 
of Foley’s latex catheters were uniformly incorporated with the 
antimicrobial agent.
In this study, catheter impregnation was achieved by dipping the 
segments into a solution which is by far simple, cheap, and easily done 
as no sophisticated equipment are required. It also does not affect the 
texture of the catheter. The process of impregnating catheters with 
antimicrobial results in complete incorporation of antimicrobial on 
matrix without any major effect on its appearance and mechanical 
properties while providing a long-lasting antimicrobial activity.
The primary testing of the processed catheter was performed by the 
bridge plate technique (Fig. 1) which showed antimicrobial activity. 
Uncoated catheter segments showed no activity. Catheters which had 
been coated using a concentration of the antimicrobial of 2 % w/v 
exhibited significant results.
According to these results, the impregnation procedure had no effect 
on the mechanical properties of the catheters. The antimicrobial 
compound had no notable effects on the catheter segments. 
Despite a load of 70 N being applied at 100 mm/min, causing an 
elongation of 100%, no fracture was observed. Statistically differences 
between control and impregnated catheters in their unused state were 
insignificant (two-tailed homoscedastic Student’s t-test) with regard to 
load, tensile strength, and modulus or between control and impregnated 
catheters after soaking in artificial urine. The control and impregnated 
balloons, before and after immersion in the synthetic urine, passed 
the test. No leakage was seen from either the control or impregnated 
balloons. The mechanical performance of the catheter and balloon 
was not adversely affected by the impregnation of the antimicrobials 
onto the catheter and balloons. The surface texture of the catheter and 
balloons remained intact.
The activity of the antibiotic-impregnated catheters against 
Gram-negative pathogens, as measured by zones of inhibition and 
recorded as E. coli 19 mm, P. aeruginosa 17 mm, Klebsiella 16.7 mm, 
Proteus 13.8 mm, Staphylococcus aureus 10 mm, and Candida 
albicans 9.4 mm.
The test catheters were able to delay the colonization by these CAUTI 
pathogens by up to about 12 weeks. The antimicrobial activity showed 
a long duration of activity. At 85 days, the antimicrobial inhibited E. coli 
while P. aeruginosa was only inhibited up to the 80th day. C. albicans was 
not inhibited beyond the 61st day (Table 1).
The assay was done so as to determine the concentration at which the 
extract showed a significant inhibition of biofilm formation. The highest 
biofilm inhibition percentage was observed at 2 mg/ml (Fig. 2).
Fig. 1: (a) Escherichia coli, (b) Staphylococcus aureus
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Figure 2: Biofilm inhibition under different concentrations
Fig. 3: Visualization of biofilm under phase contrast microscope. Untreated biofilm: (a) S. aureus, (b) E. coli, (c) Klebsiella, (d) P. 
aeruginosa, (e) Proteus, treated biofilm: (f) S. aureus (g) E. coli, (h) Klebsiella, (I) P. aeruginosa, (J) Proteus
Fig. 4: MTP assay in microtiter plate, (a): Untreated samples,  
(b) treated samples
The antimicrobial compound was characterized by FTIR. Infrared spectra 
exhibited absorption at 3402 and 3398 cm−1, indicating a hydroxyl 
group and absorption at 1655 and 1631 cm−1 indicated a double bond 
of polygenic compound while absorption at 1665, 1636, and 1631 cm−1 
indicated a hydrocarbon chassis (Fig. 5). A bioactive region was detected 
on the TLC plate; Rf 0.70. The bioactive compound exhibited a maximum 
UV absorption at 217. These strains produced either a broad-spectrum 
antimicrobial compound or several compounds with different activities.
DISCUSSION
Bacterial biofilm is formed by initial bacterial attachment which is 
reversible and is guided by physical forces like Van der Waals forces, 
and hydrophobic interactions biofilm is also formed by subsequent 
irreversible adhesion mediated by molecular reactions between bacterial 
surface structures and substratum, leading to the formation of irreversible 
biofilms. Furthermore, the ability of UTI pathogens to form biofilm on 
inanimate surfaces contributes immensely to antimicrobial resistance as 
well as impending destruction of the biofilm once formed [16].
In an effort to limit biofilm the formation, strategies like making 
the catheter surface more hydrophilic [17] with hydrogel coatings, 
impregnation of the catheter with antimicrobial ointments or 
anesthetics, and coating the catheters with antimicrobial agents such 
as antibiotics nitrofurazone and rifampicin have been tried [18].
The antibiotic also inhibited S. aureus and also C. albicans. Antimicrobial 
coated catheters have the capacity to decrease the risk of pathogen 
colonization and subsequently reduce the levels of infection [19].
According to Nooupur et al. [20], while isolate A1 showed antibacterial 
activity against both Gram-negative and Gram-positive bacteria. It 
showed maximum zone of inhibition against E. coli (20 mm) followed by P. 
Table 1: Shelf life of impregnated catheter







E. coli: Escherichia coli, S. aureus: Staphylococcus aureus, 
K. pneumonia: Klebsiella pneumonia, P. mirabilis: Proteus mirabilis, 
P. aeruginosa: Pseudomonas aeruginosa, C. albicans: Candida albicans
The antibiotic compound from Streptomyces sp. ABK 07 was able to 
reduce biofilm formation by the pathogens (Fig. 3). Biofilm was well 
established in the untreated samples as compared to the treated 
sample. The Streptomyces sp. ABK 07 extract was able to distort biofilm 
formation (Fig. 4).
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aeruginosa (18 mm), B. subtilis (17 mm), Klebsiella (5 mm), and P. vulgaris 
(13 mm) while isolate A3 showed a broad spectrum of antimicrobial 
activity against both Gram-positive, Gram-negative, and fungal pathogens.
Catheters containing single antimicrobials failed to inhibit the growth 
of pathogens unlike the catheters with combinations of antimicrobials 
like rifampicin with clindamycin hydrochloride that were able to show 
activity [11]. Impregnation of catheter with a combination of minocycline-
rifampin has been reported to produce a broad spectrum against 
Staphylococcal, Gram-negative bacillary, and Candida [21]. Chlorhexidine 
gluconate mostly used as an antiseptic and has a broad-spectrum activity.
Sherertz and group [22] demonstrated the efficacy of coating catheters 
with chlorhexidine both in vitro and in vivo. In randomized clinical 
trials, Maki et al. [2] reported that the catheters coated with tri-
iododecyclemethyl ammonium chloride and chlorhexidine gluconate 
and silver sulfadiazine decreased the risk of catheter-related septicemia 
by more than 4 times.
Vaudaux et al. [23] noted that silver is an effective antimicrobial agent 
active in a wide variety of materials including glass and polymers. The 
mechanism of antibacterial activity of silver is due to the silver ions. 
The ions bind to the electron donor groups in biological molecules and 
cause defects in bacterial cell wall. The silver ions also bind to bacterial 
DNA, thus affecting permeability and bacterial metabolism at all levels. 
Hertrick et al. [24] indicated that polymers that release silver have 
strong antibacterial property, act as reservoirs of silver, and are capable 
of releasing silver ions for extended periods and for this production of 
an effective zone of inhibition is necessary.
Most CAUTIs are caused by enterobacteria (E. coli, K. pneumoniae, and 
P. mirabilis) with minor incidences due to P. aeruginosa or C. albicans [25]. 
S. aureus is also a UTI pathogen associated with the long-term urinary 
catheters [26]. These results contradict with those recorded by Cho et al. 
[27], who dipped their catheters in a mixture of gentamicin and poly 
(ethylene-co-vinyl acetate) but reported a gentamicin release for only 
1 week and those by Rafienia et al. [28], who reported 12 days’ release 
from catheters dipped in a mixture of gentamicin - copolymer. Yahiaoui 
et al. [29] illustrated that cinnamaldehyde and eugenol in cinnamon oil 
inhibited the growth of bacterial isolates. Similar results were recorded by 
Augustine et al. [15] for their ethyl acetate extract of S. albidoflavus PU23 
whose absorption at 3296 and 1031.8 cm−1 indicated hydroxyl groups and 
absorption at 1639 cm−1 indicated a double bonding. Maximum absorbance 
peaks ranged between 215 and 270 nm. The characteristics of absorption 
peaks indicate a highly polyene nature compound. The spectral data in 
this research are consistent with those obtained by Saadoun et al. [30]. 
Mangrove actinomycetes showed the highest antimicrobial activity that 
can be exploited for various medical purposes [31].
Maleki and Mashinchian [32] reported that spectrum of ethyl acetate 
extracts of G614 C1 exhibited absorption at 3411 cm−1, which indicated 
hydroxyl groups, the absorption at 2856 and 2915 cm−1 indicated 
hydrocarbon chassis, and the absorption at 1649 cm−1 indicating a 
double bond of polygenic compound. Noopur et al. [20] reported the 
peaks of isolate A3; between 600 and 800 cm−1 showing alkyl halide, 
1080–1360 cm−1 amine group, 1400 and 1600 cm−1 aromatic group, 
1670–1820 cm−1 carbonyl group, and peaks between 1800 and 
1830 cm−1 showing anhydride group.
CONCLUSION
Conventionally available antimicrobial coated urinary catheters have 
been shown not to be effective in laboratory. Furthermore, there is no 
coated catheter available for either short-term or long-term catheter 
users, thus leaving them with the problem of reinfection. The results 
of this research suggest that the antimicrobial-impregnated catheters 
might reduce CAUTI in both short-term and long-term catheter usage.
Further studies on the antimicrobial catheter will include an in vivo 
evaluation of the impregnated catheters.
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